ʻO Captopril CAS 62571-86-2 API Hale Hana USP Kūʻai Kūʻē kiʻekiʻe
Hāʻawi Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Captopril
CAS: 62571-86-2
ʻO ka Angiotensin-Converting Enzyme (ACE) mea hōʻemi i ka hoʻohaʻahaʻa kiʻekiʻe
API Kūlana Kiʻekiʻe, Hana Hana Kūʻai
| Inoa Kimia | ʻO Captopril |
| Nā huaʻōlelo like | (S)-(-)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline;(S)-(-)-1-(3-Mercapto-2-methylpropionyl)-L-proline |
| Helu CAS | 62571-86-2 |
| Helu CAT | RF-API89 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
| ʻĀpana Molekala | C9H15NO3S |
| Kaumaha Molecular | 217.29 |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Keʻokeʻo a i ka pauka kristal keʻokeʻo |
| Hoʻāʻo | 98.0%~102.0% (ma ke kumu maloʻo) |
| Lae hehee | 104.0~110.0 ℃ |
| Hoʻololi Optical kikoʻī | -125.0° a i -134.0° |
| ʻakika | 7.0~8.0 |
| Nalo ma ka maloo | ≤1.0% |
| Koena ma ka Ignition | ≤0.10% |
| Nā Metala Kaumaha | ≤20ppm |
| Na mea pili | |
| ʻO Captopril Disulfide | ≤1.0% |
| Hoʻokahi i ʻike ʻole ʻia ka haumia | ≤0.20% |
| Huina paumaele | ≤0.50% |
| ʻO nā mea haumia kino | Kū i nā koi |
| Kūlana hoʻāʻo | Kūlana ʻoihana |
| Hoʻohana | Hoʻohana ʻia e like me ka lāʻau anti-hypertension |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
ʻO Captopril ka mea i aʻo nui ʻia o ka angiotensin-converting enzyme (ACE) inhibitors i manaʻo ʻia he lāʻau antihypertensive.Hoʻopaʻa ia i ka enzyme hoʻololi i ka angiotensin, kahi e kāohi ai i ka hoʻokumu ʻana o ka angiotensin II a hōʻoluʻolu i kāna hopena vasoconstricting ma nā moku arterial a me venous.Hoʻemi ʻia ka haʻahaʻa holoʻokoʻa vascular peripheral, kahi e hoʻohaʻahaʻa ai i ke kaomi arterial.Hōʻike ʻia ʻo Captopril, a me nā mea ACE inhibitors ʻē aʻe i ka mālama ʻana i ka hypertension, congestive heart failure, left ventricular dysfunction ma hope o ka myocardial infarction, a me ka nephropathy diabetic.I ka mālama ʻana i ka hypertension koʻikoʻi, ua manaʻo ʻia ka captopril i ka lāʻau koho mua, ʻo ia wale nō a i hui pū ʻia me ka thiazide diuretic.ʻO ka emi ʻana o ke kahe koko ma muli o ka emi ʻana o ke kūpaʻa peripheral a i ʻole ka hoʻouka ʻana.ʻO kahi pōmaikaʻi o ka hoʻohui ʻana i ka lāʻau captopril me ka thiazide diuretic maʻamau, ʻo ia ka hōʻemi ʻana o ka thiazide-induced hypokalemia i mua o ka ACE inhibition, no ka mea, aia ka emi ʻana o ka hoʻokuʻu ʻana o ka aldosterone i hoʻoiho ʻia i ka angiotensin II.
